FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Viatris Carvedilol Tablets Recall

Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc

Viatris Inc · Canonsburg, PA

Risk level
Class II
Reported by FDA
Nov 23, 2022
Recall ID
D-0063-2023
Check your lot numberHow we source this data

Summary

Viatris recalled Carvedilol Tablets starting Oct 21, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0063-2023 on Nov 23, 2022. Reason: Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.

Product description

Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05

Lot numbers, UPCs & expiration codes

Lot #: 3150116, Exp 2/2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0063-2023
Classification
Class II
Status
Terminated
Recall initiated
Oct 21, 2022
FDA report date
Nov 23, 2022
Quantity
2,794 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Viatris Inc

Original FDA data

Every field from FDA enforcement report D-0063-2023, exactly as published.

Show all FDA fields
City
Canonsburg
State
PA
Status
Terminated
Country
United States
Event ID
91038
Address
1000 Mylan Blvd
Code information
Lot #: 3150116, Exp 2/2025
Postal code
15317-5853
Report date
Nov 23, 2022
Product type
Drugs
Recall number
D-0063-2023
Classification
Class II
Recalling firm
Viatris Inc
Product quantity
2,794 bottles
Termination date
Jul 13, 2023
Reason for recall
Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 21, 2022
Initial firm notification
Letter
Center classification date
Nov 16, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0063-2023, published Nov 23, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls